📖
Development of REC1: A Reverse Vaccinology-Derived Multi-Epitope Vaccine Candidate Against Brucellosis.
Liu S, Dai Y, Huang F, Gao Z, Chen Z, Long M, Li S

Development of REC1: A Reverse Vaccinology-Derived Multi-Epitope Vaccine Candidate Against Brucellosis.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Vaccines (Basel).

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Development of REC1: A Reverse Vaccinology-Derived Multi-Epitope Vaccine Candidate Against Brucellosis.
Author / Organization Liu S, Dai Y, Huang F, Gao Z, Chen Z, Long M, Li S
Subject & Discipline Vaccines (Basel)
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-125733
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »